Suppr超能文献

计算心脏 CT 的有效剂量。

Computing effective dose in cardiac CT.

机构信息

Department of Radiology and Radiological Science, Medical University of South Carolina, 96 Jonathan Lucas Street, MSC 323, Charleston, SC 29425-3230, USA.

出版信息

Phys Med Biol. 2010 Jul 7;55(13):3675-84. doi: 10.1088/0031-9155/55/13/007. Epub 2010 Jun 9.

Abstract

We present a method of estimating effective doses in cardiac CT that accounts for selected techniques (kV mAs(-1)), anatomical location of the scan and patient size. A CT dosimetry spreadsheet (ImPACT CT Patient Dosimetry Calculator) was used to estimate effective doses (E) using ICRP 103 weighting factors for a 70 kg patient undergoing cardiac CT examinations. Using dose length product (DLP) for the same scans, we obtained values of E/DLP for three CT scanners used in cardiac imaging from two vendors. E/DLP ratios were obtained as a function of the anatomical location in the chest and for x-ray tube voltages ranging from 80 to 140 kV. We also computed the ratio of the average absorbed dose in a water cylinder modeling a patient weighing W kg to the corresponding average absorbed dose in a water cylinder equivalent to a 70 kg patient. The average E/DLP for a 16 cm cardiac heart CT scan was 26 microSv (mGy cm)(-1), which is about 70% higher than the current E/DLP values used for chest CT scans (i.e. 14-17 microSv (mGy cm)(-1)). Our cardiac E/DLP ratios are higher because the cardiac region is approximately 30% more radiosensitive than the chest, and use of the ICRP 103 tissue weighting factors increases cardiac CT effective doses by approximately 30%. Increasing the x-ray tube voltage from 80 to 140 kV increases the E/DLP conversion factor for cardiac CT by 17%. For the same incident radiation at 120 kV, doses in 45 kg adults were approximately 22% higher than those in 70 kg adults, whereas doses in 120 kg adults were approximately 28% lower. Accurate estimates of the patient effective dose in cardiac CT should use ICRP 103 tissue weighting factors, and account for a choice of scan techniques (kV mAs(-1)), exposed scan region, as well as patient size.

摘要

我们提出了一种估算心脏 CT 有效剂量的方法,该方法考虑了选定的技术(kV mAs(-1))、扫描的解剖位置和患者体型。我们使用 CT 剂量学电子表格(ImPACT CT 患者剂量计算器),根据 ICRP 103 对体重为 70kg 的患者进行心脏 CT 检查时的权重因子来估算有效剂量(E)。使用相同扫描的剂量长度乘积(DLP),我们从两个供应商的三个用于心脏成像的 CT 扫描仪中获得了 E/DLP 值。我们还获得了 E/DLP 比值与胸部解剖位置以及从 80 到 140kV 的 X 射线管电压的关系。我们还计算了一个重 Wkg 的患者水箱的平均吸收剂量与一个相当于 70kg 患者的水箱的平均吸收剂量之比。16cm 心脏 CT 扫描的平均 E/DLP 为 26μSv(mGy cm)(-1),比当前用于胸部 CT 扫描的 E/DLP 值(即 14-17μSv(mGy cm)(-1))高约 70%。我们的心脏 E/DLP 比值较高,是因为心脏区域比胸部大约敏感 30%,而且使用 ICRP 103 组织权重因子使心脏 CT 有效剂量增加了约 30%。将 X 射线管电压从 80 增加到 140kV 会使心脏 CT 的 E/DLP 转换因子增加 17%。在 120kV 相同入射辐射下,45kg 成年人的剂量比 70kg 成年人高约 22%,而 120kg 成年人的剂量则低约 28%。心脏 CT 中患者有效剂量的准确估算应使用 ICRP 103 组织权重因子,并考虑扫描技术(kV mAs(-1))、暴露扫描区域以及患者体型的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验